Speaker

Alexandra Beumer Sassi, PhD, RAC

SENIOR DIRECTOR CMC&QUALITY, VOISIN CONSULTING LIFE SCIENCES
Dr. Beumer Sassi is a Senior Director, Chemistry, Manufacturing and Controls at Voisin Consulting Life Sciences (VCLS). Dr. Beumer Sassi has over 20 years of experience in pharmaceutical/biopharmaceutical industry and consulting services. At VCLS, Dr. Beumer Sassi is responsible for the strategy and technical content of projects involving the CMC development of Biologics, Cell and Gene therapy products. She is the Global Head of the CMC & Quality team built to assist clients on bringing safe and quality innovative products to patients. She actively contributes to translation of products from discovery to clinical and marketing authorization.
Prior to joining VCLS, Dr. Beumer Sassi held different positions of growing responsibilities. Dr. Beumer Sassi started as a Principal Scientist and later on as an Investigator in BioPharmaceutical R&D department working with formulation, characterization, and development of monoclonal antibodies, then transitioning into CMC Regulatory Executive at GlaxoSmithKline.
Dr. Beumer Sassi received her Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh, and her Pharmacy degree from the University of Sao Paulo, Brazil. She completed her post-doctoral studies at Magee-Womens Research Institute in Pittsburgh. Dr. Beumer Sassi holds a US Regulatory Affairs Certification. She is an active member of the Alliance for Regenerative Medicine (ARM), the Regulatory Affairs Professional Society (RAPS), CASSS, and the Women in Bio organization.
Speaking In
11:00 AM - 12:00 PM
Wednesday, June 7
The development of cell, gene therapy, and genome editing presents several challenges. While…